U.S. markets closed

Meridian Bioscience, Inc. (VIVO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
19.07+0.48 (+2.58%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 5/12/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 0.49
52-Week Change 325.87%
S&P500 52-Week Change 341.30%
52 Week High 330.65
52 Week Low 312.98
50-Day Moving Average 322.47
200-Day Moving Average 321.72

Share Statistics

Avg Vol (3 month) 3779.33k
Avg Vol (10 day) 3632.2k
Shares Outstanding 543.33M
Implied Shares Outstanding 6N/A
Float 43.12M
% Held by Insiders 10.54%
% Held by Institutions 1103.79%
Shares Short (Apr 29, 2021) 44.57M
Short Ratio (Apr 29, 2021) 46.64
Short % of Float (Apr 29, 2021) 414.49%
Short % of Shares Outstanding (Apr 29, 2021) 410.55%
Shares Short (prior month Mar 30, 2021) 44.13M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb 13, 2019
Ex-Dividend Date 4Jan 31, 2019
Last Split Factor 23:2
Last Split Date 3May 13, 2007

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 29, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 26.62%
Operating Margin (ttm)34.12%

Management Effectiveness

Return on Assets (ttm)18.40%
Return on Equity (ttm)33.88%

Income Statement

Revenue (ttm)327.13M
Revenue Per Share (ttm)7.60
Quarterly Revenue Growth (yoy)48.80%
Gross Profit (ttm)156.25M
EBITDA 126.73M
Net Income Avi to Common (ttm)87.08M
Diluted EPS (ttm)2.00
Quarterly Earnings Growth (yoy)181.00%

Balance Sheet

Total Cash (mrq)63.37M
Total Cash Per Share (mrq)1.46
Total Debt (mrq)56.7M
Total Debt/Equity (mrq)18.32
Current Ratio (mrq)3.74
Book Value Per Share (mrq)7.14

Cash Flow Statement

Operating Cash Flow (ttm)73.75M
Levered Free Cash Flow (ttm)48.04M